Altimmune COVID-19 vaccine candidate tested at UAB shows positive preclinical results

(University of Alabama at Birmingham) Altimmune, Inc., a clinical-stage biopharmaceutical company, has announced positive results from the preclinical studies conducted in mice at the University of Alabama at Birmingham of its intranasal COVID-19 vaccine candidate, AdCOVID.

Source: EurekAlert! - Biology - July 13, 2020 Category: Biology Source Type: news